Skip to main content
Clinical Pharmacology and Therapeutics logoLink to Clinical Pharmacology and Therapeutics
. 2023 Mar 30;113(5):1161. doi: 10.1002/cpt.2893

Corrigendum: Association of Platelet Thromboxane Inhibition by Low‐Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia

PMCID: PMC10316980  PMID: 36994888

Tosetto, A., Rocca, B., Petrucci, G., Betti, S., Soldati, D., Rossi, E., Timillero, A., Cavalca, V., Porro, B., Iurlo, A., Cattaneo, D., Bucelli, C., Dragani, A., Di Ianni, M., Ranalli, P., Palandri, F., Vianelli, N., Beggiato, E., Lanzarone, G., Ruggeri, M., Carli, G., Elli, E.M., Priolo, S., Randi, M.L., Bertozzi, I., Loscocco, G.G., Ricco, A., Specchia, G., Vannucchi, A.M., Rodeghiero, F., De Stefano, V., & Patrono, C., for the Aspirin Regimens in EsSential thrombocythemia (ARES) Investigators. Clin. Pharmacol. Ther. 111, 939–949 (2022). https://doi.org/10.1002/cpt.2485.

The original publication included an incorrect affiliation for co‐authors, Francesca Palandri and Nicola Vianelli. The correct affiliation should be: IRCCS Azienda Ospedaliero‐Universitaria di Bologna, Institute of Hematology “Seràgnoli,” Bologna, Italy.

The authors apologize for the error.


Articles from Clinical Pharmacology and Therapeutics are provided here courtesy of Wiley and American Society for Clinical Pharmacology and Therapeutics

RESOURCES